https://www.sphingotec.eu/company 1.0 monthly 2026-04-02 https://www.sphingotec.eu/contact 1.0 monthly 2026-04-02 https://www.sphingotec.eu/science 1.0 monthly 2026-04-02 https://www.sphingotec.eu 1.0 monthly 2025-12-01 https://www.sphingotec.eu/news 1.0 monthly 2025-11-27 https://www.sphingotec.eu/pathophysiology 1.0 monthly 2025-11-27 https://www.sphingotec.eu/kopie-ihre-fallstudie 1.0 monthly 2025-11-27 https://www.sphingotec.eu/kopie-trends---erkenntnisse 1.0 monthly 2025-11-27 https://www.sphingotec.eu/kopie-über 1.0 monthly 2025-11-27 https://www.sphingotec.eu/kopie-home 1.0 monthly 2025-11-27 https://www.sphingotec.eu/kopie-fallstudien 1.0 monthly 2025-11-27 https://www.sphingotec.eu/kopie-kontakt 1.0 monthly 2025-11-27 https://www.sphingotec.eu/penkid-kidney-function-biomarker 1.0 monthly 2026-04-02 https://www.sphingotec.eu/initial-designs 1.0 monthly 2025-11-27 https://www.sphingotec.eu/partner-ivdr/ivdd-assays 1.0 monthly 2026-04-02 https://www.sphingotec.eu/the-implementation-of-a-novel-kidney-function-biomarker-in-clinical-routine 1.0 monthly 2025-11-27 https://www.sphingotec.eu/personalized-medicine--diagnostic-methods-transform-intensive-care-medicine 1.0 monthly 2025-11-27 https://www.sphingotec.eu/the-era-of-aki-biomarkers 1.0 monthly 2025-11-27 https://www.sphingotec.eu/seite-mit-elemente 1.0 monthly 2025-11-27 https://www.sphingotec.eu/using-proenkephalin-a-119-159-as-a-novel-biomarker-to-estimate-gfr 1.0 monthly 2025-11-27 https://www.sphingotec.eu/current-applications-of-precision-medicine-in-intensive-care-medicine 1.0 monthly 2025-11-27 https://www.sphingotec.eu/poct--a-bed-side-solution-to-a-healthcare-challenge 1.0 monthly 2025-11-27 https://www.sphingotec.eu/liberation-from-renal-replacement-therapy-in-acute-kidney-injury-patients--the-current-routine-and-insights-into-the-future 1.0 monthly 2025-11-27 https://www.sphingotec.eu/could-it-be-sepsis 1.0 monthly 2025-11-27 https://www.sphingotec.eu/privacy-notice 1.0 monthly 2026-04-02 https://www.sphingotec.eu/bio-adm-endothelial-function-biomarker 1.0 monthly 2026-04-02 https://www.sphingotec.eu/blog 1.0 monthly 2025-11-27 https://www.sphingotec.eu/pharma-collaborations 1.0 monthly 2026-04-02 https://www.sphingotec.eu/aki 1.0 monthly 2026-04-02 https://www.sphingotec.eu/sepsis 1.0 monthly 2026-04-02 https://www.sphingotec.eu/biomarker-out-licensing 1.0 monthly 2025-11-27 https://www.sphingotec.eu/collaboration 1.0 monthly 2025-11-27 https://www.sphingotec.eu/service-measurements 1.0 monthly 2026-04-02 https://www.sphingotec.eu/imprint 1.0 monthly 2025-12-01 https://www.sphingotec.eu/resources 1.0 monthly 2025-12-01 https://www.sphingotec.eu/store 1.0 monthly 2026-04-02 https://www.sphingotec.eu/proenkephalin-a-119159-penkid-leads-the-way-in-predicting-graft-outcomes-for-kidney-transplant-recipients 0.8 monthly 2025-11-27 https://www.sphingotec.eu/boditech-med-and-sphingotec-announce-launch-of-afias-penkid-assay-for-kidney-function-diagnostics 0.8 monthly 2025-11-27 https://www.sphingotec.eu/beyond-creatinine-first-real-world-evidence-highlights-proenkephalin-a-119159-penkid-as-a-valuable-kidney-function-biomarker 0.8 monthly 2025-11-27 https://www.sphingotec.eu/assessing-post-cardiac-surgery-kidney-recovery-through-penkid-s-emerging-role-in-renal-replacement-therapy-decisions 0.8 monthly 2025-11-27 https://www.sphingotec.eu/beckman-coulter-and-sphingotec-partner-to-improve-kidney-health-assessment-in-critical-care 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-closes-5m-series-c-to-accelerate-market-development-and-financial-growth-with-innovative-biomarkers 0.8 monthly 2025-11-27 https://www.sphingotec.eu/advancing-kidney-care-with-solidified-evidence-sphingotec-presents-penkid-at-aki-crrt-course-in-vicenza 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-announces-management-changes 0.8 monthly 2025-11-27 https://www.sphingotec.eu/new-formula-leverages-proenkephalin-a-119-159-penkid-for-improved-gfr-estimation-in-steady-state-and-critically-ill-patients 0.8 monthly 2025-11-27 https://www.sphingotec.eu/international-experts-highlight-demand-for-diagnostic-innovations-as-penkid-s-research-and-real-world-data-fuels-quest-for-improved-rrt-liberation-tools 0.8 monthly 2025-11-27 https://www.sphingotec.eu/boditech-med-and-sphingotec-close-market-development-agreement-to-boost-commercialization-of-kidney-function-biomarker-penkid 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-s-innovative-ivd-product-sphingotest-penkid-receives-first-ivdr-certificate 0.8 monthly 2025-11-27 https://www.sphingotec.eu/adqi-group-recognizes-penkid-as-relevant-functional-biomarker-for-sepsis-associated-acute-kidney-injury 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-appoints-dr-florian-uhle-as-medical-director 0.8 monthly 2025-11-27 https://www.sphingotec.eu/liberation-from-renal-replacement-therapy-and-early-initiation-to-be-supported-by-the-kidney-function-biomarker-proenkephalin-a-119-159-penkid 0.8 monthly 2025-11-27 https://www.sphingotec.eu/boditech-med-and-sphingotec-close-global-licensing-agreement-for-kidney-function-biomarker-proenkephalin-a-119-159-penkid 0.8 monthly 2025-11-27 https://www.sphingotec.eu/interdepartmental-testing-of-the-kidney-function-biomarker-penkid-in-routine-care-at-heidelberg-university-hospital-and-the-heidelberg-kidney-center 0.8 monthly 2025-11-27 https://www.sphingotec.eu/medical-thought-leaders-in-critical-care-aim-to-advance-precision-medicine-using-biomarker-based-approaches 0.8 monthly 2025-11-27 https://www.sphingotec.eu/endothelial-function-biomarker-bioactive-adrenomedullin-bio-adm-enables-triage-of-sepsis-patients-in-the-emergency-department 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-appoints-joerg-menten-as-ceo-to-accelerate-commercialization-and-global-growth 0.8 monthly 2025-11-27 https://www.sphingotec.eu/biomarker-guided-trial-led-by-university-hospital-hamburg-eppendorf-uke-opens-new-avenues-for-personalized-medicine-in-covid-19 0.8 monthly 2025-11-27 https://www.sphingotec.eu/the-biomarkers-bio-adm-and-dpp3-complement-post-cardiac-surgery-diagnostics-to-early-detect-organ-failure 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-and-rivaara-labs-close-exclusive-distribution-agreement-for-point-of-care-diagnostics-in-india 0.8 monthly 2025-11-27 https://www.sphingotec.eu/proenkephalin-penkid-sheds-light-on-the-diagnostic-blind-spots-in-assessing-acute-kidney-injury-in-children 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-appoints-joerg-menten-to-leadership-team-as-chief-commercial-officer-to-drive-new-business-growth 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotecs-innovative-biomarkers-to-enable-personalized-medicine-in-septic-organ-failure 0.8 monthly 2025-11-27 https://www.sphingotec.eu/new-data-on-innovative-biomarkers-used-to-guide-the-clinical-management-of-septic-patients 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-appoints-dr-gerald-moeller-as-chairman-of-the-advisory-board 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-expands-management-team-and-appoints-new-cfo 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-accelerates-growth-with-direct-sales 0.8 monthly 2025-11-27 https://www.sphingotec.eu/endothelial-function-biomarker-bio-adm-to-support-risk-stratification-and-clinical-management-of-covid-19-patients 0.8 monthly 2025-11-27 https://www.sphingotec.eu/new-diagnostic-tool-for-the-management-of-patients-with-sepsis-dipeptidyl-peptidase-3-dpp3 0.8 monthly 2025-11-27 https://www.sphingotec.eu/two-distinct-pathways-leading-to-the-development-of-septic-shock-pave-the-way-for-personalized-medicine-in-sepsis 0.8 monthly 2025-11-27 https://www.sphingotec.eu/proenkephalin-penkid-included-in-the-adqi-consensus-statements-publication-as-functional-kidney-biomarker-for-the-management-of-aki-patients 0.8 monthly 2025-11-27 https://www.sphingotec.eu/uniklinik-rwth-aachen-is-the-first-hospital-to-implement-sphingotec-s-innovative-biomarkers-in-clinical-routine-with-the-aim-of-making-intensive-care-diagnostics-more-precise 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-bhr-pharmaceuticals-ink-agreement-for-distribution-of-sphingotecs-acute-care-portfolio-in-the-uk-and-ireland 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotecs-kidney-function-biomarker-penkid-accurately-detects-acute-kidney-injury-in-infants 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-issues-convertible-note-facility 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-to-present-at-solebury-trout-s-summer-private-company-showcase 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-to-present-at-lifesci-partners-summer-symposium 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-launches-point-of-care-test-for-bio-adm-a-biomarker-for-life-threatening-endothelial-dysfunction 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotecs-critical-care-biomarkers-early-diagnose-risk-of-loss-of-endothelial-kidney-and-heart-function-in-severely-ill-covid-19-patients 0.8 monthly 2025-11-27 https://www.sphingotec.eu/the-cardiac-depressant-factor-dpp3-is-predicting-organ-failure-in-burn-patients 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-expands-leadership-team-and-appoints-achim-plum-as-managing-director-and-chief-commercial-officer 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-s-endothelial-function-biomarker-bio-adm-improves-risk-stratification-of-sepsis-patients-at-icus 0.8 monthly 2025-11-27 https://www.sphingotec.eu/bioactive-adrenomedullin-measured-with-sphingotecs-bio-adm-assay-plays-a-key-role-in-septic-shock-patients-as-top-line-results-of-adrenoss-2-phase-ii-study-indicate 0.8 monthly 2025-11-27 https://www.sphingotec.eu/novel-data-on-sphingotec-s-biomarkers-for-acute-and-critical-care-setting-to-be-presented-at-aki-crrt-2020 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-s-biomarker-penkid-shows-best-representation-of-true-glomerular-filtration-rate-and-has-utility-in-patients-with-sever-burns-two-studies-show 0.8 monthly 2025-11-27 https://www.sphingotec.eu/hitado-gmbh-becomes-nexus-ib10-distributor-for-sphingotec-in-germany-an-switzerland 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-launches-ivd-test-for-kidney-function-biomarker-penkid-on-nexus-ib10-poct-platform 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-transforms-into-end-to-end-diagnostic-solutions-provider-and-exclusively-represents-nexus-dx-ib10-immunoassay-portfolio 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotecs-endothelial-function-biomarker-bio-adm-predicts-need-for-organ-support-in-general-icu-patient-population 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotecs-biomarker-penkid-predicts-septic-acute-kidney-injury-at-time-of-admission-to-emergency-department 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotecs-proprietary-biomarker-bio-adm-detects-residual-congestion-in-patients-with-heart-failure 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-to-present-novel-acute-care-biomarkers-and-point-of-care-diagnostic-solutions-at-medica-2019 0.8 monthly 2025-11-27 https://www.sphingotec.eu/novel-data-on-sphingotecs-penkid-kidney-function-assay-to-be-presented-at-32nd-esicm-annual-congress-2019 0.8 monthly 2025-11-27 https://www.sphingotec.eu/dipeptidyl-peptidase-3-dpp3-cause-of-acute-myocardial-depression-sphingotec-launches-first-ivd-test-for-dpp3-on-nexus-ib10-point-of-care-platform 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-reveals-novel-results-on-bioactive-adrenomedullin-for-diagnosis-and-therapy-monitoring-of-septic-shock-at-the-39th-international-symposium-on-intensive-care-and-emergency-medicine-isicem 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-announces-new-data-on-the-kidney-function-marker-proenkephalin-penkid-presented-at-24th-international-conference-on-advances-in-critical-care-nephrology 0.8 monthly 2025-11-27 https://www.sphingotec.eu/endothelial-disruption-rapid-translation-from-bench-to-bedside 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-raises-20-million-from-hbm-and-wellington-partners 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-is-adding-an-advanced-poc-testing-platform-to-portfolio 0.8 monthly 2025-11-27 https://www.sphingotec.eu/medical-leaders-support-novel-theragnostic-approach-to-help-patients-with-leaky-blood-vessels 0.8 monthly 2025-11-27 https://www.sphingotec.eu/ortho-clinical-diagnostics-and-sphingotec-announce-strategic-agreement-regarding-novel-biomarker-for-decreasing-re-hospitalizations-in-heart-failure 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-announces-collaboration-with-mayo-clinic-for-evaluation-and-use-of-biomarkers 0.8 monthly 2025-11-27 https://www.sphingotec.eu/review-paper-on-proenkephalin-as-a-novel-biomarker-for-kidney-function 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-and-shuwen-biotech-partner-to-market-sphingotecs-biomarkers-portfolio-in-china 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-and-bestbion-dx-partner-to-market-predictive-biomarkers-for-guidance-of-therapy-in-acute-heart-failure-and-septic-shock 0.8 monthly 2025-11-27 https://www.sphingotec.eu/good-microcirculation-indicates-increased-lifespan 0.8 monthly 2025-11-27 https://www.sphingotec.eu/survey-majority-of-women-do-not-discuss-breast-cancer-risks-or-mammography-screening-limitations-with-healthcare-providers 0.8 monthly 2025-11-27 https://www.sphingotec.eu/researchers-link-low-levels-of-pro-enkephalin-to-future-breast-cancer-in-healthy-women 0.8 monthly 2025-11-27 https://www.sphingotec.eu/majority-of-women-do-not-discuss-breast-cancer-risks-with-healthcare-provider 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-at-the-st-gallen-international-breast-cancer-conference 0.8 monthly 2025-11-27 https://www.sphingotec.eu/sphingotec-and-genenews-limited-innovative-diagnostics-laboratory-idl-sign-a-licensing-and-cooperation-agreement-for-the-u-s-market 0.8 monthly 2025-11-27 https://www.sphingotec.eu/product/CLIA-sphingotest-penKid 1.0 monthly 2026-04-02 https://www.sphingotec.eu/product/ELISA-sphingotest-penKid 1.0 monthly 2026-04-02 https://www.sphingotec.eu/product/CLIA-sphingotest-bio-ADM 1.0 monthly 2026-04-02 https://www.sphingotec.eu/product/sphingotest-lightning 1.0 monthly 2026-04-02 https://www.sphingotec.eu/category/accessories 1.0 monthly 2026-04-02 https://www.sphingotec.eu/category/ELISA 1.0 monthly 2026-04-02